bioRxiv · 10.1101/2020.07.06.189696
A DNA-based optical nanosensor for in vivo imaging of acetylcholine in the peripheral nervous system
Abstract
The ability to monitor the release of neurotransmitters during synaptic transmission would significantly impact the diagnosis and treatment of neurological disease. Here, we present a DNA-based enzymatic nanosensor for quantitative detection of acetylcholine (ACh) in the peripheral nervous system of living mice. ACh nanosensors consist of DNA as a scaffold, acetylcholinesterase as a recognition component, pH-sensitive fluorophores as signal generators, and -bungarotoxin as a targeting moiety. We demonstrate the utility of the nanosensors in the submandibular ganglia of living mice to sensitively detect ACh ranging from 0.228 M to 358 M. In addition, the sensor response upon electrical stimulation of the efferent nerve is dose-dependent, reversible, and we observe a reduction of ~76% in sensor signal upon pharmacological inhibition of ACh release. Equipped with an advanced imaging processing tool, we further spatially resolve ACh signal propagation on the tissue level. Our platform enables sensitive measurement and mapping of ACh transmission in the peripheral nervous system.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Xia, J., Yang, H., Mu, M., Micovic, N., Poskanzer, K. E., Monaghan, J. R., Clark, H. A.. 2020-07-06. A DNA-based optical nanosensor for in vivo imaging of acetylcholine in the peripheral nervous system. https://doi.org/10.1101/2020.07.06.189696
Cite the original work for its findings. Save a collection to share your selection of sources.